Skip to main content
OpenTrials
Completed

NCT Number: NCT02970422

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Montreal Chest Institute of the McGill University Health Center (MUHC)

Montreal, Quebec, H4A 3J1, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of COPD
  • English or French speaking
  • Patient at one of the three participating sites with medical chart

Exclusion criteria

  • No diagnosis of COPD by a healthcare professional
  • Unable to communicate in English or French
  • Unable to provide informed consent
  • No medical chart information at one of the three participating sites

Treatment and study plan

patient survey

Other

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Primary outcomes

  1. Number of Participants Who Prioritized Healthcare Topics

    Time frame: Baseline

    Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.

  2. Number of Participants Who Prioritized Research Topics

    Time frame: Baseline

    Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.

  3. Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities

    Time frame: Baseline

    Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below.

    Activity 1: Walking from one place to another outside of your home on a flat surface.

    Activity 2: Moving from one place to another using motorized transportation.

    Activity 3: Climbing two or more flights of stairs.

    Activity 4: Walking up a hill.

    Activity 5: Participating in regular exercise.

    Activity 6: Walking from one place to another in your home.

    Activity 7: Carrying light objects on a flat surface.

    Activity 8: Carrying heavy objects on a flat surface.

    Activity 9: Carrying-out low intensity physical activities

Secondary outcomes

  1. Forced Expiratory Volume in 1-sec (FEV1)

    Time frame: Baseline

    Individuals forced expiratory volume in 1-sec (FEV1) as assessed by spirometry

  2. FEV1/FVC

    Time frame: Baseline

    Individuals FEV1-to-forced vital capacity (FVC) ratio

  3. Modified Medical Research Council Questionnaire on Breathlessness

    Time frame: Baseline

    Self-reported intensity of activity related breathlessness as assessed by the modified Medical Research Council (mMRC) dyspnea scale (0-4). This questionnaire was used to measure participants' breathlessness burden using a single item scale from 0 to 4, where a score of 0-1 indicated mild breathlessness and 2-4 indicated increased breathlessness.

  4. COPD Assessment Test

    Time frame: Baseline

    This questionnaire measure the impact COPD is having on well being and daily life. The CAT is an eight-item semantic differential scale from 0 to 5, where 0 is no impact and 5 is extremely impactful. Items include: I never cough| I cough all the time, I have no phlegm (mucus) in my chest at all | My chest is completely full of phlegm (mucus), My chest does not feel tight at all | My chest feels very tight, When I walk up a hill or one flight of stairs, I am not breathless | When I walk up a hill or one flight of stairs, I am very breathless, I am not limited doing any activities at home| I am very limited doing activities at home, I am confident leaving my home despite my lung condition| I am not at all confident leaving my home because of my lung condition, I sleep soundly | I don't sleep soundly because of my lung condition, I have lots of energy I have no energy at all. Participants' scores were totaled and a score of ≥ 10 indicated higher than normal burden of disease.

  5. Godin Leisure Time Physical Activity Questionnaire

    Time frame: Baseline

    Self-reported physical activity levels measured in length of bouts over the previous 7 days to determine physical activity frequency.

  6. Satisfaction of Life Questionnaire

    Time frame: Baseline

    This 5 item questionnaire was used to measure participants' level of life satisfaction. The higher the score, the higher the sense of life satisfaction. A score from 5-9 indicated extremely dissatisfied, 10-14 is dissatisfied, 15-19 indicated slightly below average life satisfaction. 20-24 is the average score, 25-29 is a high score indicative of higher life satisfaction and a score between 30-35 is a very high score and represent very high life satisfaction.

  7. Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months

    Time frame: baseline

    An exacerbation was defined as a change in medication due to a COPD exacerbation (i.e., the prescription of prednisone or a medical action plan) as indicated in the medical chart or hospital admission due to a COPD exacerbation.

Sponsors and collaborators

Lead sponsor

McGill University

Other

Collaborators

  • AstraZeneca

Registry information

Official study title

COPD Patient Preferences, Activities, and Participation Survey

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Nov 22, 2016
Registry last updated
Dec 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.